Clinical Trials on Pancreatic Neoplasm in Colombia
Total 4756 results
-
Vertex Pharmaceuticals IncorporatedTerminatedPancreatic CancerUnited States
-
Gilead SciencesTerminatedPreviously Untreated Pancreatic Ductal Adenocarcinoma | Relapsed/Refractory Pancreatic Ductal AdenocarcinomaUnited States
-
H. Kim LyerlyNational Cancer Institute (NCI)CompletedBreast Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
British Columbia Cancer AgencyNo longer availableThyroid Cancer, Medullary | Neuroblastoma | Pheochromocytoma | Carcinoid Tumor | Paraganglioma | InsulinomaCanada
-
Georgetown UniversityNational Cancer Institute (NCI)CompletedBreast Cancer | Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Gilead SciencesCompletedPancreatic NeoplasmsUnited States, Germany, Hungary, Netherlands
-
SanofiCompletedPancreatic NeoplasmsUnited States, Brazil, Poland, Russian Federation, Germany, Turkey, India, Belgium, Czech Republic, Mexico, Chile, Finland, Hungary, Italy, Norway, Canada, Colombia, Peru, Slovakia, Spain, United Kingdom
-
British Columbia Cancer AgencyWithdrawnNeuroendocrine Tumors | Carcinoid Tumor | Gastrinoma | Insulinoma | Vipoma | Gastroenteropancreatic Neuroendocrine Tumor | Pulmonary Carcinoid TumorCanada
-
Eli Lilly and CompanyCompletedPancreatic CancerCanada, United States, Israel, Norway, United Kingdom
-
Duke UniversityMerck Sharp & Dohme LLC; IpsenCompletedGastroenteropancreatic Neuroendocrine TumorsUnited States
-
Georgetown UniversityCompletedPancreatic Cancer | Breast Neoplasm | BRCA1 Mutation | BRCA2 Mutation | Prostate CarcinomaUnited States
-
GERCOR - Multidisciplinary Oncology Cooperative...UnknownPancreatic CancerFrance, Luxembourg
-
RenovoRxRecruitingLocally Advanced Pancreatic CancerUnited States, Belgium
-
GenVecCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedPancreatic CancerUnited States
-
Halozyme TherapeuticsCompletedMetastatic Pancreatic CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingCarcinoid Tumor | Functioning Pancreatic Neuroendocrine Tumor | Intermediate Grade Lung Neuroendocrine Neoplasm | Locally Advanced Pancreatic Neuroendocrine Tumor | Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm | Low Grade Lung Neuroendocrine Neoplasm | Metastatic Digestive... and other conditionsUnited States
-
NewLink Genetics CorporationCompleted
-
Biological DynamicsDana-Farber Cancer Institute; Medical College of WisconsinRecruitingPancreatic Neoplasms | Pancreas Cancer | Extracellular Vesicles | ExosomesUnited States
-
GERCOR - Multidisciplinary Oncology Cooperative...Unknown
-
Novartis PharmaceuticalsTerminatedSolid Tumors for Phase Ib | Pancreatic Cancer for Phase II | Colorectal Cancer for Phase IIUnited States, Canada, Australia, Belgium, Germany, Netherlands, Spain
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic CancerPancreatic CancerUnited States, Canada
-
Royal Liverpool University HospitalNCIC Clinical Trials Group; Australasian Gastro-Intestinal Trials GroupCompletedPancreatic CancerFrance, Australia, Canada, Sweden, Switzerland, Finland, Japan, Germany, United Kingdom, Italy, Czech Republic, Greece, Hungary
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Southwest...CompletedPancreatic CancerUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedPancreatic CancerUnited States, Puerto Rico
-
Panbela Therapeutics, Inc.RecruitingPancreatic Cancer Metastatic | Pancreatic Ductal Adenocarcinoma | Pancreatic Cancer Stage IVUnited States, Belgium, Germany, Spain, Korea, Republic of, Australia, France, Italy, Austria, United Kingdom
-
Incyte CorporationTerminatedPancreatic CancerUnited States, France, Colombia, Israel, Portugal, Netherlands, Chile, Puerto Rico, Sweden, Austria, Denmark, Mexico, Ireland, Switzerland
-
CelgeneCompletedPancreatic CancerUnited States, Canada, Spain, Australia, France, Germany, Austria, Italy, Ukraine
-
National Cancer Institute (NCI)CompletedLocally Advanced Pancreatic Neuroendocrine Tumor | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2 | Pancreatic Vipoma | Pancreatic Gastrinoma | Advanced Pancreatic Neuroendocrine TumorUnited States, Canada
-
National Cancer Institute (NCI)RecruitingPancreatic Acinar Cell Carcinoma | Pancreatic Adenosquamous Carcinoma | Pancreatic Squamous Cell Carcinoma | Resectable Pancreatic Acinar Cell Carcinoma | Resectable Pancreatic Adenocarcinoma | Resectable Pancreatic Adenosquamous Carcinoma | Resectable Pancreatic CarcinomaUnited States
-
European Organisation for Research and Treatment...Federation Francophone de Cancerologie DigestiveCompletedPancreatic CancerFrance, Switzerland, Belgium, Israel, Germany, Netherlands
-
MorphotekCompletedPancreatic CancerUnited States, Canada, Spain, Belgium, Germany
-
Eli Lilly and CompanyCompletedPancreatic Neoplasms | Metastases, NeoplasmUnited States, France, United Kingdom, Germany, Taiwan, Spain, Belgium, Portugal, Peru, Austria, Italy, Sweden, Netherlands, Venezuela, Argentina, Australia, Colombia, Greece
-
Therion Biologics CorporationUnknownPancreatic CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingPancreatic Cancer | Pancreatic Adenosquamous Carcinoma | Resectable Pancreatic AdenocarcinomaUnited States, Canada
-
Hoffmann-La RocheCompletedPancreatic CancerBelgium, France, Germany, Italy, Spain, Australia, Canada, Czech Republic, Singapore, New Zealand, Austria, China, Netherlands, South Africa, United Kingdom, Israel, Peru, Finland, Poland, Taiwan, Sweden
-
Hoffmann-La RocheActive, not recruitingPancreatic AdenocarcinomaUnited States, Spain, Korea, Republic of, Germany, Japan
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingPancreatic CarcinomaUnited States, Canada, Korea, Republic of, Puerto Rico
-
National Cancer Institute (NCI)RecruitingPancreatic Adenocarcinoma | Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic AdenocarcinomaUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedPancreatic CancerUnited States, Canada
-
Arbor Research Collaborative for HealthRecruitingPancreatic Ductal Adenocarcinoma | Pancreas Cancer | Genetic Predisposition | Pancreas CystUnited States, Italy, Canada, Israel, Spain, United Kingdom, Iceland, Taiwan, Singapore, Hungary
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingStage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic AdenocarcinomaUnited States
-
National Cancer Institute (NCI)CompletedPancreatic Ductal Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage IV Pancreatic Cancer | Pancreatic Acinar Cell CarcinomaUnited States
-
Threshold PharmaceuticalsPPDCompletedPancreatic CancerUnited States, Brazil, Ukraine, India, Russian Federation, Romania, Hungary, Mexico, Argentina, Bulgaria, Czech Republic
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Pancreatic Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage IV Pancreatic Cancer AJCC v6 and v7United States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedPancreatic Adenocarcinoma | Resectable Pancreatic CarcinomaUnited States
-
Eli Lilly and CompanyARMO BioSciencesCompletedPancreatic CancerUnited States, Belgium, Spain, Poland, Korea, Republic of, Taiwan, Germany, Italy, France, United Kingdom, Austria, Australia, Canada
-
Gilead SciencesCompletedPancreatic CancerUnited States, Russian Federation
-
OSI PharmaceuticalsCanadian Cancer Trials GroupCompletedPancreatic CancerUnited States, Canada, Australia, Israel, Singapore, United Kingdom, Germany, Belgium, Romania, Poland, Argentina, Brazil, Chile, Greece, Italy, Mexico, New Zealand
-
Merus N.V.RecruitingNSCLC Harboring NRG1 Fusion | Solid Tumours Harboring NRG1 Fusion | Pancreatic Cancer Harboring NRG1 Fusion | NRG1 FusionSpain, France, Israel, Belgium, Denmark, United States, Korea, Republic of, Japan, Germany, Netherlands, Austria, Canada, Italy, Norway, Singapore, Sweden, Taiwan, United Kingdom